Wake Forest University Health Sciences
Winston-Salem, North Carolina, 271757, United States
NCT Number: NCT00959660
The purpose of this study is to examine the effects of weight loss via hypocaloric diet, aerobic exercise training, combined hypocaloric diet and exercise training, and attention control in patients with heart failure and a normal ejection fraction (HFNEF) and body mass index greater than or equal to 30.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Winston-Salem, North Carolina, 271757, United States
Heart failure with a normal ejection fraction (HFNEF, previously termed diastolic heart failure), accounts for the majority of heart failure cases in the population > 65 years old and has been recognized as a true geriatric syndrome. Exercise intolerance is the primary chronic symptom of HFNEF and a major determinant of these patients' severely reduced quality of life; however little is known regarding its pathophysiology and treatment. Therefore, our work has focused on understanding the pathophysiology of exercise intolerance in HFNEF and developing and testing interventions that may improve this pivotal outcome in this highly prevalent disorder of older persons. The aims of the proposed study are to conduct a randomized, controlled, single-blinded, 2x2 design trial to examine the effects of weight loss via hypocaloric diet, aerobic exercise training, combined hypocaloric diet and exercise training, and attention control in patients with HFNEF and body mass index >30 in order to test the following hypotheses: 1) Both weight loss and exercise training will improve exercise intolerance and quality of life in older, obese patients with HFNEF; 2) The combination of weight loss and exercise training will produce complementary effects on body and thigh muscle composition and additive improvements in exercise intolerance in HFNEF; 3) Improvements in exercise intolerance will correlate with improvements in lean body mass, reversal of adverse thigh muscle remodeling, and increased thigh muscle capillarity. The study has the potential to significantly advance our understanding of exercise intolerance and its treatment in the large population of older persons with HFNEF.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
walking, treadmill and bicycle exercise
Subjects will be provided meals and instructions for individual food selections.
Subjects will be provided meals and instructions for individual food selections and will undergo walking, treadmill and bicycle exercise.
control group- continue their previously randomized life style
Time frame: 20 weeks
Exercise capacity assessed as Peak VO2 (ml/kg/min) via treadmill cardiopulmonary exercise testing using the modified Naughton protocol to the end point of exhaustion.
Time frame: 20 weeks
Heart failure-specific quality of life was assessed with the Kansas City Cardiomyopathy Questionnaire (KCCQ) on a range 0-100; higher scores indicate better quality of life.
Time frame: 20 weeks
Total Body Fat Mass and Total Non-bone Lean Mass via DEXA
Time frame: 20 weeks
Thigh Skeletal Muscle and Subcutaneous Fat via MRI
Wake Forest University
Other
Study of the Effect of Caloric Restriction and Exercise Training in Patients With Heart Failure and a Normal Ejection Fraction.(SECRET)
Acronym: SECRET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02636439
Body Weight, Cardiovascular Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03448185
Body Weight, Cardiovascular Diseases
Dallas, Texas, United States
View Trial DetailsNCT07554638
Body Weight, Cardiovascular Diseases
View Trial DetailsNCT05887271
Body Weight, Cardiovascular Diseases
Leicester, Leicestershire, United Kingdom
View Trial Details